Management and outcome of BK viremia in renal transplant recipients: A prospective single-center study

Transplantation

Volumn 94, Issue 8, 2012, Pages 814-821

  Sood, Puneet ^a   Senanayake, Shamila ^a   Sujeet, Kumar ^a   Medipalli, Radhika ^a   Zhu, Yong R ^a   Johnson, Christopher P ^a   Hariharan, Sundaram ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

BK virus; Immunosuppression; Infection; Kidney; Rejection

Indexed keywords

ANTIVIRUS AGENT; BASILIXIMAB; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; AGED; BK VIRUS INFECTION; BLOOD LEVEL; BOLUS INJECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DNA BLOOD LEVEL; DNA DETERMINATION; DNA URINE LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVIEW; TREATMENT OUTCOME; URINE LEVEL; VIREMIA;

ADULT; AGED; BIOPSY; BK VIRUS; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEPHRITIS; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA;

EID: 84868207563     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31826690c6     Document Type: Review

References (26)

1. Lipshutz GS, Flechner SM, Govani MV, et al. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitorYfree immunosuppression regimen. Am J Transplant 2004; 4: 2132.
2. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirusassociated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
3. Pallet N, Burgard M, Quamouss O, et al. Cidofovir may be deleterious in BK virusYassociated nephropathy. Transplantation 2010; 89: 1542.
4. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year followup of renal allograft recipients. Transplantation 2006; 81: 117.
5. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirusassociated nephropathy (PVAN). Am J Transplant 2006; 6: 1025.
6. Johnston O, Jaswal D, Gill JS, et al. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 2010; 89: 1057.
7. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
8. Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5: 1926.
9. Hussain S, Bresnahan BA, Cohen EP, et al. Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. Clin Transplant 2002; 16: 43.
10. Trofe J, Hirsch HH, Ramos E. Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients. Transpl Infect Dis 2006; 8: 76.
11. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006; 69: 655.
12. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
13. Hardinger KL, KochMJ, Bohl DJ, et al. BK-virus and the impact of preemptive immunosuppression reduction: 5-year results. Am J Transplant 2010; 10: 407.
14. Guasch A, Roy-Chaudhury P, Woodle ES, et al. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 2010; 90: 891.
15. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 2008; 85: 850.
16. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
17. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virusYassociated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103.
18. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834.
19. Weiss AS, Gralla J, Chan L, et al. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virusYassociated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol 2008; 3: 1812.
20. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
21. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615.
22. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
23. Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311.
24. Hoffman NG, Cook L, Atienza EE, et al. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol 2008; 46: 2671.
25. Sood P, Senanayake S, Sujeet K, et al. Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study. Transplantation 2012; 93: 291.
26. Bonvoisin C, Weekers L, Xhignesse P, et al. Polyomavirus in renal transplantation: a hot problem. Transplantation 2008; 85: S42.